nodes	percent_of_prediction	percent_of_DWPC	metapath
Sufentanil—OPRM1—nicotine dependence	0.978	1	CbGaD
Sufentanil—Remifentanil—OPRM1—nicotine dependence	0.00287	0.322	CrCbGaD
Sufentanil—Anileridine—OPRM1—nicotine dependence	0.0028	0.314	CrCbGaD
Sufentanil—Alfentanil—OPRM1—nicotine dependence	0.00238	0.267	CrCbGaD
Sufentanil—Fentanyl—OPRM1—nicotine dependence	0.000872	0.0976	CrCbGaD
Sufentanil—Euphoric mood—Varenicline—nicotine dependence	0.000811	0.105	CcSEcCtD
Sufentanil—Urinary retention—Varenicline—nicotine dependence	0.000652	0.0842	CcSEcCtD
Sufentanil—Bradycardia—Varenicline—nicotine dependence	0.000483	0.0623	CcSEcCtD
Sufentanil—Urinary tract disorder—Varenicline—nicotine dependence	0.000468	0.0605	CcSEcCtD
Sufentanil—Urethral disorder—Varenicline—nicotine dependence	0.000465	0.06	CcSEcCtD
Sufentanil—Chills—Varenicline—nicotine dependence	0.000426	0.0549	CcSEcCtD
Sufentanil—Arrhythmia—Varenicline—nicotine dependence	0.000424	0.0547	CcSEcCtD
Sufentanil—Erythema—Varenicline—nicotine dependence	0.000413	0.0533	CcSEcCtD
Sufentanil—Hypertension—Varenicline—nicotine dependence	0.000356	0.046	CcSEcCtD
Sufentanil—Tachycardia—Varenicline—nicotine dependence	0.000329	0.0425	CcSEcCtD
Sufentanil—Hypotension—Varenicline—nicotine dependence	0.000315	0.0407	CcSEcCtD
Sufentanil—Somnolence—Varenicline—nicotine dependence	0.0003	0.0387	CcSEcCtD
Sufentanil—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000287	0.0502	CbGpPWpGaD
Sufentanil—Feeling abnormal—Varenicline—nicotine dependence	0.000278	0.0358	CcSEcCtD
Sufentanil—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00027	0.0472	CbGpPWpGaD
Sufentanil—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000268	0.0468	CbGpPWpGaD
Sufentanil—Body temperature increased—Varenicline—nicotine dependence	0.000266	0.0344	CcSEcCtD
Sufentanil—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000252	0.044	CbGpPWpGaD
Sufentanil—Hypersensitivity—Varenicline—nicotine dependence	0.000248	0.0321	CcSEcCtD
Sufentanil—Pruritus—Varenicline—nicotine dependence	0.000238	0.0308	CcSEcCtD
Sufentanil—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000237	0.0414	CbGpPWpGaD
Sufentanil—Dizziness—Varenicline—nicotine dependence	0.000223	0.0288	CcSEcCtD
Sufentanil—Vomiting—Varenicline—nicotine dependence	0.000214	0.0277	CcSEcCtD
Sufentanil—Rash—Varenicline—nicotine dependence	0.000212	0.0274	CcSEcCtD
Sufentanil—Dermatitis—Varenicline—nicotine dependence	0.000212	0.0274	CcSEcCtD
Sufentanil—Headache—Varenicline—nicotine dependence	0.000211	0.0273	CcSEcCtD
Sufentanil—Nausea—Varenicline—nicotine dependence	0.0002	0.0258	CcSEcCtD
Sufentanil—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0002	0.035	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000163	0.0286	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000143	0.0251	CbGpPWpGaD
Sufentanil—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000135	0.0236	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000121	0.0212	CbGpPWpGaD
Sufentanil—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000118	0.0207	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000114	0.0199	CbGpPWpGaD
Sufentanil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000111	0.0194	CbGpPWpGaD
Sufentanil—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00011	0.0192	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000106	0.0185	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	9.98e-05	0.0175	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	9.26e-05	0.0162	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	9.24e-05	0.0162	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	9.05e-05	0.0158	CbGpPWpGaD
Sufentanil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	9.01e-05	0.0158	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	8.39e-05	0.0147	CbGpPWpGaD
Sufentanil—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	8.23e-05	0.0144	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	8.1e-05	0.0142	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	7.94e-05	0.0139	CbGpPWpGaD
Sufentanil—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	7.64e-05	0.0134	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	7.36e-05	0.0129	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	7.25e-05	0.0127	CbGpPWpGaD
Sufentanil—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	7.22e-05	0.0126	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	6.89e-05	0.0121	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	6.85e-05	0.012	CbGpPWpGaD
Sufentanil—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	6.7e-05	0.0117	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	6.58e-05	0.0115	CbGpPWpGaD
Sufentanil—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	6.54e-05	0.0114	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	6.36e-05	0.0111	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	6.22e-05	0.0109	CbGpPWpGaD
Sufentanil—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	6.1e-05	0.0107	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	6.04e-05	0.0106	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	5.77e-05	0.0101	CbGpPWpGaD
Sufentanil—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	5.74e-05	0.01	CbGpPWpGaD
Sufentanil—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	5.66e-05	0.0099	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	5.37e-05	0.0094	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	5.07e-05	0.00888	CbGpPWpGaD
Sufentanil—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	4.98e-05	0.00872	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	4.96e-05	0.00867	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	4.88e-05	0.00854	CbGpPWpGaD
Sufentanil—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	4.85e-05	0.00848	CbGpPWpGaD
Sufentanil—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	4.78e-05	0.00837	CbGpPWpGaD
Sufentanil—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	4.72e-05	0.00826	CbGpPWpGaD
Sufentanil—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	4.37e-05	0.00764	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	4.35e-05	0.0076	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	3.89e-05	0.00681	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—FGD1—nicotine dependence	3.89e-05	0.0068	CbGpPWpGaD
Sufentanil—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	3.69e-05	0.00646	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	3.67e-05	0.00643	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	3.54e-05	0.00619	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	3.44e-05	0.00601	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	3.41e-05	0.00598	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—FGD1—nicotine dependence	3.41e-05	0.00597	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	3.1e-05	0.00543	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	3.01e-05	0.00527	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—FGD1—nicotine dependence	2.88e-05	0.00504	CbGpPWpGaD
Sufentanil—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	2.82e-05	0.00493	CbGpPWpGaD
Sufentanil—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	2.56e-05	0.00447	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	2.55e-05	0.00445	CbGpPWpGaD
Sufentanil—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	2.47e-05	0.00432	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—WASF2—nicotine dependence	2.42e-05	0.00423	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—WASF1—nicotine dependence	2.32e-05	0.00406	CbGpPWpGaD
Sufentanil—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	2.24e-05	0.00392	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—WASF2—nicotine dependence	2.12e-05	0.00371	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	2.09e-05	0.00366	CbGpPWpGaD
Sufentanil—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	2.09e-05	0.00365	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—WASF1—nicotine dependence	2.03e-05	0.00356	CbGpPWpGaD
Sufentanil—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	1.89e-05	0.00332	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	1.83e-05	0.00321	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—WASF2—nicotine dependence	1.79e-05	0.00314	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—WASF1—nicotine dependence	1.72e-05	0.00301	CbGpPWpGaD
Sufentanil—OPRD1—Signaling Pathways—DRD2—nicotine dependence	1.51e-05	0.00264	CbGpPWpGaD
Sufentanil—OPRK1—Signaling Pathways—DRD2—nicotine dependence	1.32e-05	0.00232	CbGpPWpGaD
Sufentanil—OPRM1—Signaling Pathways—DRD2—nicotine dependence	1.12e-05	0.00196	CbGpPWpGaD
Sufentanil—CYP3A4—Metabolism—CYP2A7—nicotine dependence	8.18e-06	0.00143	CbGpPWpGaD
